| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABI1
|
abl-interactor 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACADSB
|
acyl-CoA dehydrogenase, short/branched chain
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ACTN1
|
actinin, alpha 1
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ACVR1
|
activin A receptor, type I
|
|
ADAM2
|
ADAM metallopeptidase domain 2
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AGO3
|
argonaute RISC catalytic component 3
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AIRE
|
autoimmune regulator
|
|
AKAP11
|
A kinase (PRKA) anchor protein 11
|
|
AKR1C1
|
aldo-keto reductase family 1, member C1
|
|
AKR1C4
|
aldo-keto reductase family 1, member C4
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALAD
|
aminolevulinate dehydratase
|
|
ALAS2
|
5'-aminolevulinate synthase 2
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALDH4A1
|
aldehyde dehydrogenase 4 family, member A1
|
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
ALX4
|
ALX homeobox 4
|
|
AMH
|
anti-Mullerian hormone
|
|
AMPD1
|
adenosine monophosphate deaminase 1
|
|
AMY1A
|
amylase, alpha 1A (salivary)
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPT4
|
angiopoietin 4
|
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
ANKRD1
|
ankyrin repeat domain 1 (cardiac muscle)
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
ANXA5
|
annexin A5
|
|
ANXA7
|
annexin A7
|
|
APBA1
|
amyloid beta (A4) precursor protein-binding, family A, member 1
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APOM
|
apolipoprotein M
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP7
|
aquaporin 7
|
|
AR
|
androgen receptor
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
ARL15
|
ADP-ribosylation factor-like 15
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ARSB
|
arylsulfatase B
|
|
AS3MT
|
arsenite methyltransferase
|
|
ASF1A
|
anti-silencing function 1A histone chaperone
|
|
ASF1B
|
anti-silencing function 1B histone chaperone
|
|
ASIC1
|
acid sensing (proton gated) ion channel 1
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide
|
|
AURKB
|
aurora kinase B
|
|
AVP
|
arginine vasopressin
|
|
B2M
|
beta-2-microglobulin
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAX
|
BCL2-associated X protein
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCLAF1
|
BCL2-associated transcription factor 1
|
|
BCR
|
breakpoint cluster region
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BHLHE41
|
basic helix-loop-helix family, member e41
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRINP1
|
bone morphogenetic protein/retinoic acid inducible neural-specific 1
|
|
BSG
|
basigin (Ok blood group)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
C10ORF2
|
chromosome 10 open reading frame 2
|
|
C12ORF10
|
chromosome 12 open reading frame 10
|
|
C5AR1
|
complement component 5a receptor 1
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA2D2
|
calcium channel, voltage-dependent, alpha 2/delta subunit 2
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALR
|
calreticulin
|
|
CANX
|
calnexin
|
|
CAPN10
|
calpain 10
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBX4
|
chromobox homolog 4
|
|
CBX8
|
chromobox homolog 8
|
|
CBY1
|
chibby homolog 1 (Drosophila)
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
|
CCL4L2
|
chemokine (C-C motif) ligand 4-like 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCNL1
|
cyclin L1
|
|
CCNT1
|
cyclin T1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD163
|
CD163 molecule
|
|
CD200
|
CD200 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD28
|
CD28 molecule
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD47
|
CD47 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD8A
|
CD8a molecule
|
|
CD99
|
CD99 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2B-AS1
|
CDKN2B antisense RNA 1
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CENPH
|
centromere protein H
|
|
CFH
|
complement factor H
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA6
|
cholinergic receptor, nicotinic, alpha 6 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHRNB3
|
cholinergic receptor, nicotinic, beta 3 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
CLCN2
|
chloride channel, voltage-sensitive 2
|
|
CLOCK
|
clock circadian regulator
|
|
CNNM2
|
cyclin and CBS domain divalent metal cation transport mediator 2
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNTF
|
ciliary neurotrophic factor
|
|
COIL
|
coilin
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL6A5
|
collagen, type VI, alpha 5
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPE
|
carboxypeptidase E
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CRACR2A
|
calcium release activated channel regulator 2A
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRY1
|
cryptochrome circadian clock 1
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CST3
|
cystatin C
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSL
|
cathepsin L
|
|
CTTN
|
cortactin
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYB5A
|
cytochrome b5 type A (microsomal)
|
|
CYB5R3
|
cytochrome b5 reductase 3
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYCS
|
cytochrome c, somatic
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2
|
|
CYP7B1
|
cytochrome P450, family 7, subfamily B, polypeptide 1
|
|
DAO
|
D-amino-acid oxidase
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DBNL
|
drebrin-like
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDX17
|
DEAD (Asp-Glu-Ala-Asp) box helicase 17
|
|
DDX25
|
DEAD (Asp-Glu-Ala-Asp) box helicase 25
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEPDC5
|
DEP domain containing 5
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DNAH1
|
dynein, axonemal, heavy chain 1
|
|
DNM1L
|
dynamin 1-like
|
|
DNM2
|
dynamin 2
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DSG1
|
desmoglein 1
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DUX4L1
|
double homeobox 4 like 1
|
|
DZIP1
|
DAZ interacting zinc finger protein 1
|
|
E2F1
|
E2F transcription factor 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
|
EFNB1
|
ephrin-B1
|
|
EFNB2
|
ephrin-B2
|
|
EGF
|
epidermal growth factor
|
|
EGFL7
|
EGF-like-domain, multiple 7
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
EIF2B1
|
eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa
|
|
EIF2B2
|
eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa
|
|
EIF2B3
|
eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa
|
|
EIF2B4
|
eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa
|
|
EIF2B5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELF1
|
E74-like factor 1 (ets domain transcription factor)
|
|
ELN
|
elastin
|
|
EMD
|
emerin
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EP300
|
E1A binding protein p300
|
|
EPB41
|
erythrocyte membrane protein band 4.1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FADS1
|
fatty acid desaturase 1
|
|
FADS2
|
fatty acid desaturase 2
|
|
FAM3B
|
family with sequence similarity 3, member B
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBLN5
|
fibulin 5
|
|
FBXO25
|
F-box protein 25
|
|
FBXO4
|
F-box protein 4
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FGB
|
fibrinogen beta chain
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FKBP5
|
FK506 binding protein 5
|
|
FKBP8
|
FK506 binding protein 8, 38kDa
|
|
FKBPL
|
FK506 binding protein like
|
|
FLCN
|
folliculin
|
|
FLG
|
filaggrin
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
|
FOXL2
|
forkhead box L2
|
|
FOXO1
|
forkhead box O1
|
|
FOXP1
|
forkhead box P1
|
|
FOXP2
|
forkhead box P2
|
|
FOXP3
|
forkhead box P3
|
|
FPR2
|
formyl peptide receptor 2
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTO
|
fat mass and obesity associated
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FUS
|
FUS RNA binding protein
|
|
FUT1
|
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group)
|
|
FUT7
|
fucosyltransferase 7 (alpha (1,3) fucosyltransferase)
|
|
FXN
|
frataxin
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAA
|
glucosidase, alpha; acid
|
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
|
GALNS
|
galactosamine (N-acetyl)-6-sulfatase
|
|
GAMT
|
guanidinoacetate N-methyltransferase
|
|
GAS7
|
growth arrest-specific 7
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GATA4
|
GATA binding protein 4
|
|
GBA
|
glucosidase, beta, acid
|
|
GCG
|
glucagon
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
|
GCLM
|
glutamate-cysteine ligase, modifier subunit
|
|
GCNT1
|
glucosaminyl (N-acetyl) transferase 1, core 2
|
|
GDF15
|
growth differentiation factor 15
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GEM
|
GTP binding protein overexpressed in skeletal muscle
|
|
GFER
|
growth factor, augmenter of liver regeneration
|
|
GFPT1
|
glutamine--fructose-6-phosphate transaminase 1
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLCCI1
|
glucocorticoid induced 1
|
|
GLO1
|
glyoxalase I
|
|
GLS
|
glutaminase
|
|
GM2A
|
GM2 ganglioside activator
|
|
GNAS
|
GNAS complex locus
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GOT1
|
glutamic-oxaloacetic transaminase 1, soluble
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRK4
|
G protein-coupled receptor kinase 4
|
|
GRP
|
gastrin-releasing peptide
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
H6PD
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HBB
|
hemoglobin, beta
|
|
HBE1
|
hemoglobin, epsilon 1
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC5
|
histone deacetylase 5
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1
|
|
HFE
|
hemochromatosis
|
|
HFE2
|
hemochromatosis type 2 (juvenile)
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HMOX1
|
heme oxygenase 1
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HRH4
|
histamine receptor H4
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTT
|
huntingtin
|
|
HYAL1
|
hyaluronoglucosaminidase 1
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM2
|
intercellular adhesion molecule 2
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFI27
|
interferon, alpha-inducible protein 27
|
|
IFN1@
|
interferon, type 1, cluster
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNL3
|
interferon, lambda 3
|
|
IFNL4
|
interferon, lambda 4 (gene/pseudogene)
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGKC
|
immunoglobulin kappa constant
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL10
|
interleukin 10
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL12B
|
interleukin 12B
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
|
IL13
|
interleukin 13
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
|
IL17A
|
interleukin 17A
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL23R
|
interleukin 23 receptor
|
|
IL24
|
interleukin 24
|
|
IL27
|
interleukin 27
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
IMPACT
|
impact RWD domain protein
|
|
INHBC
|
inhibin, beta C
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IPMK
|
inositol polyphosphate multikinase
|
|
IREB2
|
iron-responsive element binding protein 2
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRGM
|
immunity-related GTPase family, M
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRX4
|
iroquois homeobox 4
|
|
ISCU
|
iron-sulfur cluster assembly enzyme
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB3BP
|
integrin beta 3 binding protein (beta3-endonexin)
|
|
ITGB5
|
integrin, beta 5
|
|
ITK
|
IL2-inducible T-cell kinase
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNA4
|
potassium channel, voltage gated shaker related subfamily A, member 4
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNE4
|
potassium channel, voltage gated subfamily E regulatory beta subunit 4
|
|
KCNJ10
|
potassium channel, inwardly rectifying subfamily J, member 10
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ3
|
potassium channel, voltage gated KQT-like subfamily Q, member 3
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDR
|
kinase insert domain receptor
|
|
KIF6
|
kinesin family member 6
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DL5A
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A
|
|
KIR2DL5B
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5B
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KISS1R
|
KISS1 receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KL
|
klotho
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
|
KLRD1
|
killer cell lectin-like receptor subfamily D, member 1
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT16
|
keratin 16, type I
|
|
LAMA3
|
laminin, alpha 3
|
|
LCAT
|
lecithin-cholesterol acyltransferase
|
|
LCT
|
lactase
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEAP2
|
liver expressed antimicrobial peptide 2
|
|
LEP
|
leptin
|
|
LEPQTL1
|
Leptin, serum levels of
|
|
LEPR
|
leptin receptor
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
LIF
|
leukemia inhibitory factor
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LIMS1
|
LIM and senescent cell antigen-like domains 1
|
|
LIPC
|
lipase, hepatic
|
|
LMAN1
|
lectin, mannose-binding, 1
|
|
LMNA
|
lamin A/C
|
|
LMNB1
|
lamin B1
|
|
LNPEP
|
leucyl/cystinyl aminopeptidase
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPCAT1
|
lysophosphatidylcholine acyltransferase 1
|
|
LPL
|
lipoprotein lipase
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTF
|
lactotransferrin
|
|
LUM
|
lumican
|
|
MAD2L1BP
|
MAD2L1 binding protein
|
|
MAML1
|
mastermind-like 1 (Drosophila)
|
|
MAOA
|
monoamine oxidase A
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MB21D1
|
Mab-21 domain containing 1
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC3R
|
melanocortin 3 receptor
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCFD2
|
multiple coagulation factor deficiency 2
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN1
|
mitofusin 1
|
|
MFN2
|
mitofusin 2
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIR106B
|
microRNA 106b
|
|
MIR124-1
|
microRNA 124-1
|
|
MIR126
|
microRNA 126
|
|
MIR142
|
microRNA 142
|
|
MIR148A
|
microRNA 148a
|
|
MIR150
|
microRNA 150
|
|
MIR155
|
microRNA 155
|
|
MIR17
|
microRNA 17
|
|
MIR195
|
microRNA 195
|
|
MIR196A1
|
microRNA 196a-1
|
|
MIR200C
|
microRNA 200c
|
|
MIR20A
|
microRNA 20a
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR29A
|
microRNA 29a
|
|
MIR328
|
microRNA 328
|
|
MIR335
|
microRNA 335
|
|
MIR375
|
microRNA 375
|
|
MIR451A
|
microRNA 451a
|
|
MIR502
|
microRNA 502
|
|
MIR519C
|
microRNA 519c
|
|
MIRLET7A3
|
microRNA let-7a-3
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MLANA
|
melan-A
|
|
MLF1
|
myeloid leukemia factor 1
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPO
|
myeloperoxidase
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MSR1
|
macrophage scavenger receptor 1
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MT3
|
metallothionein 3
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
MUTYH
|
mutY homolog
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYO1C
|
myosin IC
|
|
NAA10
|
N(alpha)-acetyltransferase 10, NatA catalytic subunit
|
|
NACC1
|
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NANOG
|
Nanog homeobox
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NDUFS4
|
NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase)
|
|
NES
|
nestin
|
|
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGB
|
neuroglobin
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOG
|
noggin
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NPY
|
neuropeptide Y
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NRXN1
|
neurexin 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
NUP62
|
nucleoporin 62kDa
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OR7D4
|
olfactory receptor, family 7, subfamily D, member 4
|
|
OXTR
|
oxytocin receptor
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
P2RY11
|
purinergic receptor P2Y, G-protein coupled, 11
|
|
PAH
|
phenylalanine hydroxylase
|
|
PAPL
|
iron/zinc purple acid phosphatase-like protein
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX4
|
paired box 4
|
|
PCLO
|
piccolo presynaptic cytomatrix protein
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDHA1
|
pyruvate dehydrogenase (lipoamide) alpha 1
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PDPN
|
podoplanin
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PER2
|
period circadian clock 2
|
|
PER3
|
period circadian clock 3
|
|
PEX1
|
peroxisomal biogenesis factor 1
|
|
PGK1
|
phosphoglycerate kinase 1
|
|
PGR
|
progesterone receptor
|
|
PGRMC1
|
progesterone receptor membrane component 1
|
|
PHF11
|
PHD finger protein 11
|
|
PHKA2
|
phosphorylase kinase, alpha 2 (liver)
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLP1
|
proteolipid protein 1
|
|
PLTP
|
phospholipid transfer protein
|
|
PMP22
|
peripheral myelin protein 22
|
|
PNP
|
purine nucleoside phosphorylase
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
PODXL
|
podocalyxin-like
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POLL
|
polymerase (DNA directed), lambda
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
POR
|
P450 (cytochrome) oxidoreductase
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPM1A
|
protein phosphatase, Mg2+/Mn2+ dependent, 1A
|
|
PPP2R5A
|
protein phosphatase 2, regulatory subunit B', alpha
|
|
PRC1
|
protein regulator of cytokinesis 1
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCG
|
protein kinase C, gamma
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRLR
|
prolactin receptor
|
|
PRM1
|
protamine 1
|
|
PRM2
|
protamine 2
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PRODH
|
proline dehydrogenase (oxidase) 1
|
|
PROM1
|
prominin 1
|
|
PSD3
|
pleckstrin and Sec7 domain containing 3
|
|
PSEN1
|
presenilin 1
|
|
PSMC4
|
proteasome (prosome, macropain) 26S subunit, ATPase, 4
|
|
PTCH1
|
patched 1
|
|
PTCHD2
|
patched domain containing 2
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
RAD51
|
RAD51 recombinase
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RBM3
|
RNA binding motif (RNP1, RRM) protein 3
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELN
|
reelin
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RFC1
|
replication factor C (activator 1) 1, 145kDa
|
|
RFWD2
|
ring finger and WD repeat domain 2, E3 ubiquitin protein ligase
|
|
RGS1
|
regulator of G-protein signaling 1
|
|
RHAG
|
Rh-associated glycoprotein
|
|
RHOA
|
ras homolog family member A
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RORA
|
RAR-related orphan receptor A
|
|
RORC
|
RAR-related orphan receptor C
|
|
RPS19BP1
|
ribosomal protein S19 binding protein 1
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RTN4R
|
reticulon 4 receptor
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RXFP1
|
relaxin/insulin-like family peptide receptor 1
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
S100B
|
S100 calcium binding protein B
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCGB2A1
|
secretoglobin, family 2A, member 1
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SCRIB
|
scribbled planar cell polarity protein
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SELPLG
|
selectin P ligand
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SETDB1
|
SET domain, bifurcated 1
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFN
|
stratifin
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFRP5
|
secreted frizzled-related protein 5
|
|
SFTPD
|
surfactant protein D
|
|
SHANK2
|
SH3 and multiple ankyrin repeat domains 2
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIRT1
|
sirtuin 1
|
|
SIRT3
|
sirtuin 3
|
|
SLC15A1
|
solute carrier family 15 (oligopeptide transporter), member 1
|
|
SLC16A4
|
solute carrier family 16, member 4
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC22A2
|
solute carrier family 22 (organic cation transporter), member 2
|
|
SLC23A1
|
solute carrier family 23 (ascorbic acid transporter), member 1
|
|
SLC23A2
|
solute carrier family 23 (ascorbic acid transporter), member 2
|
|
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC46A1
|
solute carrier family 46 (folate transporter), member 1
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC6A8
|
solute carrier family 6 (neurotransmitter transporter), member 8
|
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLX4
|
SLX4 structure-specific endonuclease subunit
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMG1
|
SMG1 phosphatidylinositol 3-kinase-related kinase
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNX20
|
sorting nexin 20
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOCS7
|
suppressor of cytokine signaling 7
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SORT1
|
sortilin 1
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SPAST
|
spastin
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPR
|
sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SQSTM1
|
sequestosome 1
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SREBF2
|
sterol regulatory element binding transcription factor 2
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
SRSF7
|
serine/arginine-rich splicing factor 7
|
|
SSTR1
|
somatostatin receptor 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STMN1
|
stathmin 1
|
|
STX11
|
syntaxin 11
|
|
SUN1
|
Sad1 and UNC84 domain containing 1
|
|
SV2C
|
synaptic vesicle glycoprotein 2C
|
|
SYNE2
|
spectrin repeat containing, nuclear envelope 2
|
|
TAC1
|
tachykinin, precursor 1
|
|
TARBP2
|
TAR (HIV-1) RNA binding protein 2
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAS2R38
|
taste receptor, type 2, member 38
|
|
TAZ
|
tafazzin
|
|
TBK1
|
TANK-binding kinase 1
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TF
|
transferrin
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGM2
|
transglutaminase 2
|
|
TGM4
|
transglutaminase 4
|
|
TGM5
|
transglutaminase 5
|
|
THBD
|
thrombomodulin
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
|
TIMELESS
|
timeless circadian clock
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TK2
|
thymidine kinase 2, mitochondrial
|
|
TLK1
|
tousled-like kinase 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TLR9
|
toll-like receptor 9
|
|
TMC6
|
transmembrane channel-like 6
|
|
TMC8
|
transmembrane channel-like 8
|
|
TMEM173
|
transmembrane protein 173
|
|
TMPO
|
thymopoietin
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10C
|
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
|
|
TNFRSF10D
|
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNP1
|
transition protein 1 (during histone to protamine replacement)
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TRAF3IP2
|
TRAF3 interacting protein 2
|
|
TRAP1
|
TNF receptor-associated protein 1
|
|
TREM2
|
triggering receptor expressed on myeloid cells 2
|
|
TRMT10A
|
tRNA methyltransferase 10 homolog A (S. cerevisiae)
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
|
TSG101
|
tumor susceptibility 101
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TTN
|
titin
|
|
TTR
|
transthyretin
|
|
TUSC3
|
tumor suppressor candidate 3
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UBE3B
|
ubiquitin protein ligase E3B
|
|
UCN2
|
urocortin 2
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
UNC93B1
|
unc-93 homolog B1 (C. elegans)
|
|
UPF1
|
UPF1 regulator of nonsense transcripts homolog (yeast)
|
|
USP9Y
|
ubiquitin specific peptidase 9, Y-linked
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VDAC2
|
voltage-dependent anion channel 2
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VWF
|
von Willebrand factor
|
|
WBP1L
|
WW domain binding protein 1-like
|
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT16
|
wingless-type MMTV integration site family, member 16
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT9A
|
wingless-type MMTV integration site family, member 9A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
WWC1
|
WW and C2 domain containing 1
|
|
XBP1
|
X-box binding protein 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
XYLT1
|
xylosyltransferase I
|
|
YBX1
|
Y box binding protein 1
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZFHX3
|
zinc finger homeobox 3
|
|
ZRSR2
|
zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2
|
